Patient expectations high as level of surgery advances
Samuel Masket, MD, challenges young U.S. physicians to further the state of anterior segment eye surgery
Editor’s Note: In this ongoing series of one-on-one interviews with key ophthalmic leaders, J.C. Noreika, MD, MBA, talks with Samuel Masket, MD, clinical professor of ophthalmology, David Geffen School of Medicine, Jules Stein Eye Institute, University of California, Los Angeles (UCLA). In his practice that manages complex cases, Dr. Masket sees a high volume of patients referred for dysphotopsia and addresses issues related to the condition. Dr. Masket also highlights some of his many achievements and contributions to cataract and refractive surgery and tracks the field’s trends—from the infancy of phacoemulsification and lens implant cataract surgery to femtosecond lasers and extended depth-of-focus IOLs.
Dr. Noreika: Please tell us a little about yourself and your career.
Dr. Masket: I finished my training in 1973 and then spent 2 years on active duty with the U.S. Navy, as there was still a physician draft and I had been deferred to complete my residency. I spent a very short time practicing in the East, and in 1977 came to Southern California and established an academic association with the Jules Stein Eye Institute at UCLA that I have maintained since that time and I have been a clinical professor for many years.
Moreover, I have served as editor for the consultation section of the Journal of Cataract and Refractive Surgery for nearly 25 years. I am also a member of the Editorial Advisory Board of Ophthalmology Times.
I had the honor of presenting the Binkhorst Lecture at the American Academy of Ophthalmology (AAO) in 1998, and this past year I gave the Kelman Lecture. Most recently, during the 2014 meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, I gave the Jan Worst Medal Lecture at the International Intraocular Implant Club annual meeting.
Over my career, I have had the remarkable opportunity to interact globally with many colleagues and have had the honor of being a guest and named lecturer in varied countries, and still hold ORBIS missions dear to my heart. I was very privileged to have been president of ASCRS and a member of the Board of Trustees of the AAO.
I was very fortunate to be around during the infancy of phacoemulsification. When I started performing phaco in 1980, fewer than 5% of surgeons were using the technology. I learned phaco by watching Dick Kratz, MD, who was very instrumental in the early part of my career. I hold him in extremely high regard for his honesty with his patients, his surgical skills, and his innovation.
NEXT: Page 2 + Podcast